Stay updated on Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page.

Latest updates to the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision history updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedThe updates include a minor footer revision (v3.4.2) and removal of an older funding-status notice; no changes to trial details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedAdded a site-wide notice about government funding lapse and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedAdded a glossary toggle label and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The prior wording for QC updates and 'Revision: v3.3.4' has been removed.SummaryDifference0.2%

- Check73 days agoChange DetectedFooter revision tag updated from v3.3.3 to v3.3.4; no study data, eligibility criteria, or trial results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page.